Publication of a Letter to Shareholders – May 2015
Publication of a Letter to Shareholders – May 2015
Onxeo S.A. (Euronext Paris, NASDAQ Copenhagen: ONXEO), an innovative company specializing in the development of orphan oncology drugs, today announces the publication of the Letter to Shareholders - May 2015.